Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer
Clinical trial NCT00777101 · COMPLETED
Trial details
- NCT number
- NCT00777101
- Sponsor
- Puma Biotechnology, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-04
- Primary completion
- 2011-03-01
- Enrollment
- 233
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.